Chemical synthesis, NMR analysis and evaluation on a cancer xenograft model (HL-60) of the aminosteroid derivative RM-133

Steroids. 2014 Apr:82:68-76. doi: 10.1016/j.steroids.2014.01.008. Epub 2014 Jan 30.

Abstract

The aminosteroid derivative RM-133 has been reported to be a promising pro-apoptotic agent showing activity on various cancer cell lines. Following the development of solid-phase synthesis that generated a series of libraries of aminosteroid derivatives, we now report the development of a convenient liquid phase chemical synthesis of RM-133, the most promising candidate, in order to obtain sufficient quantities to proceed with the first preclinical assays. A simple and convergent six-step synthesis was designed and allowed the preparation of a gram-quantity scale of RM-133. This aminosteroid derivative was also fully characterized by NMR experiments which revealed an interesting mixture of conformers. Finally, the in vivo potency of RM-133 was evaluated on a xenograft model in nude mice with HL-60 tumors, which has resulted in the blocking of tumor progression by 57%.

Keywords: Cancer; Leukemia; NMR; Synthesis; Xenograft.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstenes / chemical synthesis
  • Androstenes / chemistry
  • Androstenes / pharmacology*
  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • HL-60 Cells
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mice
  • Mice, Nude
  • Molecular Conformation
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / pathology
  • Structure-Activity Relationship
  • Xenograft Model Antitumor Assays*

Substances

  • Androstenes
  • Antineoplastic Agents
  • RM-133 aminosteroid